Zydus Lifesciences Limited U.S. subsidiary Zydus Pharmaceuticals (USA) Inc. has received tentative approval from the United States Food and Drug Administration (USFDA) to market Amantadine Extended-Release Capsules USP 68.5 mg and 137 mg (USRLD: Gocovri).
- Read more about Zydus receives tentative approval from the USFDA for Amantadine Extended-Release Capsules
- Log in or register to post comments
source https://www.pharmatutor.org/pharma-news/2022/zydus-receives-tentative-approval-from-the-usfda-for-amantadine-extended-release-capsules
No comments:
Post a Comment